Biogen Inc.
BIIB
$184.02
-$4.03-2.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.89B | 10.07B | 10.00B | 9.82B | 9.68B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.89B | 10.07B | 10.00B | 9.82B | 9.68B |
| Cost of Revenue | 2.48B | 2.57B | 2.65B | 2.66B | 2.58B |
| Gross Profit | 7.41B | 7.49B | 7.34B | 7.15B | 7.09B |
| SG&A Expenses | 2.43B | 2.43B | 2.41B | 2.38B | 2.39B |
| Depreciation & Amortization | 507.10M | 486.10M | 460.50M | 420.00M | 386.50M |
| Other Operating Expenses | 290.20M | 277.40M | 259.50M | 246.90M | 254.40M |
| Total Operating Expenses | 7.07B | 7.18B | 7.28B | 7.20B | 7.11B |
| Operating Income | 2.82B | 2.89B | 2.72B | 2.62B | 2.57B |
| Income Before Tax | 1.56B | 1.90B | 1.80B | 1.75B | 1.91B |
| Income Tax Expenses | 263.60M | 295.50M | 267.20M | 273.10M | 273.80M |
| Earnings from Continuing Operations | 1.29K | 1.61K | 1.53K | 1.48K | 1.63K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.29B | 1.61B | 1.53B | 1.48B | 1.63B |
| EBIT | 2.82B | 2.89B | 2.72B | 2.62B | 2.57B |
| EBITDA | 3.60B | 3.65B | 3.47B | 3.32B | 3.24B |
| EPS Basic | 8.83 | 10.99 | 10.48 | 10.15 | 11.21 |
| Normalized Basic EPS | 10.85 | 11.55 | 10.75 | 10.31 | 9.99 |
| EPS Diluted | 8.81 | 10.96 | 10.45 | 10.12 | 11.18 |
| Normalized Diluted EPS | 10.83 | 11.52 | 10.72 | 10.28 | 9.96 |
| Average Basic Shares Outstanding | 585.90M | 584.90M | 584.00M | 583.10M | 582.20M |
| Average Diluted Shares Outstanding | 587.10M | 586.50M | 585.50M | 584.70M | 584.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |